iCo Therapeutics Inc.

iCo Therapeutics is an emerging Vancouver-based biotechnology company committed to developing drugs for a range of human medical conditions within ‘isolated biological environments’, such as the eye, spinal cord or joints. Focusing on these isolated biological systems allows a drug to reach commercialization faster and more efficiently since non-systemic (local) administration has the potential for fewer risks and safety issues

Contact Details: 760-777 Hornby Street Vancouver British Columbia V6Z 1S4 Canada Tel: 604.602.9414 Fax: 604.602.9699 Email: info@icotherapeutics.com WWW: www.icotherapeutics.com/

Loading...

Press Releases on iCo Therapeutics Inc.:
Isis Reports Financial Results and Highlights for Third Quarter of 2008	10th November, 2008	Isis Pharmaceuticals, Inc.	CARLSBAD, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced its financial results for the third quarter ended September 30, 2008. Isis'
Migenix averts proxy contest; reaches agreement with DJohnson holdings	11th August, 2008	MIGENIX Inc.	VANCOUVER, Aug. 11 /PRNewswire-FirstCall/ - MIGENIX Inc. ("MIGENIX") announced today that it has reached an agreement with DJohnson Holdings Inc. ("DJohnson"), a significant

BioNews Results for iCo Therapeutics Inc.:
iCo Therapeutics Completes Final Tranche of $4,000,000 Brokered Private Placement	TickerTech.com:  Nov 21 2009 8:42PM Matching: ico therapeutics inc
iCo Therapeutics Completes Final Tranche of $4,000,000 Brokered Private Placement	Yahoo! Canada:  Nov 21 2009 4:40AM Matching: ico therapeutics inc
iCo Therapeutics announces $4,000,000 brokered private placement	News-Medical.Net:  Oct 31 2009 6:06AM Matching: ico therapeutics inc
iCo Therapeutics Completes First Tranche of Brokered Private Placement	Yahoo! Canada:  Oct 30 2009 9:55PM Matching: ico therapeutics inc
Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009	News-Medical.Net:  Oct 22 2009 3:25PM Matching: ico therapeutics inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more iCo Therapeutics Inc. news.

iCo Therapeutics Inc. Clinical Trials:
Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 267 times since April 2007, the link to the organisation's website has been followed 52 times

Recent Search Terms used to find this page: iCo Therapeutics Inc | .

Search for more companies in Vancouver

Search for more companies in British Columbia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for iCo Therapeutics Inc.